Ayala Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AYLA and buy or sell other stocks, ETFs, and their options commission-free!About AYLA
Old Ayala, Inc. operates as a clinical-stage oncology company. It focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers.
CEOKen Berlin
CEOKen Berlin
Employees—
Employees—
HeadquartersRehovot, Tel Aviv
HeadquartersRehovot, Tel Aviv
Founded2017
Founded2017
Employees—
Employees—
AYLA Key Statistics
Market cap7.46M
Market cap7.46M
Price-Earnings ratio-0.20
Price-Earnings ratio-0.20
Dividend yield—
Dividend yield—
Average volume63.91K
Average volume63.91K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$7.13
52 Week high$7.13
52 Week low$0.3568
52 Week low$0.3568
Stock Snapshot
As of today, Ayala Pharmaceuticals(AYLA) shares are valued at $0.50. The company's market cap stands at 7.46M, with a P/E ratio of -0.20.
During the trading day, Ayala Pharmaceuticals(AYLA) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Ayala Pharmaceuticals(AYLA) stock has reached 0, versus its average volume of 63.91K.
Over the past 52 weeks, Ayala Pharmaceuticals(AYLA) stock has traded between a high of $7.13 and a low of $0.36.
Over the past 52 weeks, Ayala Pharmaceuticals(AYLA) stock has traded between a high of $7.13 and a low of $0.36.
People also own
Based on the portfolios of people who own AYLA. This list is generated using Robinhood data, and it’s not a recommendation.